Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0408

View: 3988 Download: 72 Web of Science: 2 Crossref: 3

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 23865 Download: 1,386 Web of Science: 82 Crossref: 80

Review

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 18419 Download: 954 Web of Science: 73 Crossref: 77

3

Clinical features of patients with fulminant hepatitis A requiring emergency Liver transplantation: comparison with acute Liver failure due to other causes

Jin Dong Kim, M.D., Jong Young Choi, M.D., Chung-Hwa Park, M.D., Myeong Jun Song, M.D., Jeong Won Jang, M.D., Si Hyun Bae, M.D., Seung Kew Yoon, M.D., Young Sok Lee, M.D., Young Kyoung You, M.D. Dong Goo Kim, M.D.

Clin Mol Hepatol. 2010;16(1):19-28. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.19

View: 6360 Download: 107 Crossref: 9

2

Acute Liver failure in Korea: etiology, prognosis and treatment

Young Suk Lim

Clin Mol Hepatol. 2010;16(1):5-18. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.5

View: 6827 Download: 136 Crossref: 11

3

Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A

Jwa Min Kim , Yoon Seon Lee , Jae Ho Lee , Won Kim , Kyung Soo Lim

Clin Mol Hepatol. 2008;14(4):474-482. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.474

View: 6121 Download: 72 Crossref: 19

The Role of Neuropsychological Testing and Electroencephalogram for Early Detection of Minimal Hepatic Encephalopathy

Choon Shik Choi, M.D., Byung Ik Kim, M.D. Min Ho Lee, M.D., Ho Soon Choi, M.D., Seok Hyeon Kim, M.D. and Dong Hyun Ahn, M.D.

Clin Mol Hepatol. 2005;11(4):329-338. Published online January 1, 1970

View: 2716 Download: 22

Clinical Features and Prognostic Factors of Fulminant Hepatic Failure in Koreans

Sung Jae Shin , Sang Hoon Ahn , Hee Man Kim , Ja Kyung Kim , Byung Chang Kim , Jae Hyun Lee , Yong Han Paik , Kwan Sik Lee , Kwang Hyub Han , Chae Yoon Chon , Young Myou

Clin Mol Hepatol. 2004;10(4):298-307.

View: 3132 Download: 18

Gastric pH and Helicobacter pylori Infection in Patients with Liver Cirrhosis

Yeong Jin Nam, M.D., Seong Jun Kim, M.D., Won Chang Shin, M.D., Jin Ho Lee, M.D., Won Choong Choi, M.D., Kwan Yeop Kim, M.D. and Tae Hui Han, M.D.*

Clin Mol Hepatol. 2004;10(3):216-222. Published online January 1, 2000

View: 3107 Download: 37

Efficacy and Safety of Short-term Administration of Rifaximin in the Treatment of Hepatic Encephalopathy

Myoung Hwan Kim, M.D., Kwang Hyub Han, M.D., Kwan Sik Lee, M.D., Yong Han Paik, M.D., Kun Hoon Song, M.D., Ho Kyun Na, M.D., Byung Soo Moon, M.D., Suk Hwa Yoon, R.N ., Chae Yoon Chon, M.D., Young Myoung Moon, M.D. In Suh Park, M.D.

Clin Mol Hepatol. 2001;7(1):55-60. Published online January 1, 2000

View: 2781 Download: 22

Relationship to Magnetic Resonance Signal Hyperintensity in Globus Pallidus and Blood Manganese Concentration in Cirrhotic Patients with Extrapyramidal Symptoms

Il Hyun Baek, M.D., Byung-Ho Kim, M.D., Dong Kuen Lee, M.D., Yo Seb Han, M.D., Dae Il Jang, M.D.*, Woo Suk Choi, M.D.†, Kyung Jin Kim, M.D., Seok Ho Dong, M.D., Hyo Jong Kim, M.D., Young Woon Chang, M.D., Joung Il Lee, M.D., Rin Chang, M.D.

Clin Mol Hepatol. 2000;6(1):24-32. Published online January 1, 2000

View: 2480 Download: 13

1 |

Viewed By 7179	MAFLD: How is it different from NAFLD?
Viewed By 6617	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5463	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5256	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 269	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 181	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search